FDA Clearance Tracker · P950032-S028
APILGRAF(GRAFTSKIN)
Last checked: Nov 20, 2026Latest source record: Jan 17, 2002 (this decision)Source: openFDAMethods & limitations
Decided
Jan 17, 2002
Approved
Time to decision
85 days
Received Oct 24, 2001. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P950032-S028
- Device name
- APILGRAF(GRAFTSKIN)
- Applicant
- Organogenesis, Inc.
- Applicant location
- Canton, MA
- Received
- Oct 24, 2001
- Decided
- Jan 17, 2002
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Other
- Original approval
- P950032
Device type
- Device type
- Dressing, wound and burn, interactive (MGR)
- Device class
- Class III
- Specialty
- General & Plastic SurgeryWound Care
FDA's approval statement
As written in FDA's record.
APPROVAL FOR REMOVAL OF THE CMV IGG ANTIBODY TEST FROM THE ANTEPARTUM MATERNAL DONOR SERUM TESTING PANEL, WHILE CONTINUING TO TEST THE MATERNAL DONOR SERA FOR CMV IGM ANTIBODIES AND THE MASTER CELL BANK FOR CMV VIA PCR.
Source documents
Other decisions for Organogenesis, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K212579 · Decided May 2, 2023 · 624 days after receipt
Device type: Wound Dressing With Animal-Derived Material(S) (KGN) · General & Plastic Surgery
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.